Understanding the needs of the patient can ensure that patient-centric trials complete on time and on budget.
TORONTO (PRWEB) March 10, 2021
Within the last 5 years, the well-received Patient’s Voice conference has developed into one of the most important meeting points in the pharma sector, bringing together patients, pharma industry leaders, responsible study specialists, site professionals and physicians. Due to COVID-19, this year’s Patient’s Voice will be an online event, giving participants the opportunity to have first-hand access to patients’ perspectives, in order to implement them into the drug development process.
Understanding the patient is the cornerstone to a successful trial. In this webinar, panelists from the patient and sponsor side will teach participants how to design and implement patient-friendly protocols and feasible clinical trials.
Understanding the needs of the patient can ensure that patient-centric trials complete on time and on budget. The patient needs to be at the center of R&D decision making.
Join Amy Froment, Head of Global Trial Optimization, Regeneron U.K., and Dr. Andree Beckerling, CEO, CLARINESS, in a live webinar on Thursday, March 25, 2021 at 11am EDT (3pm GMT/UK) to listen to, learn about and understand the needs of 5 invited patient speakers who have participated in clinical trials, or who are still considering their options.
For more information, or to register for this event, visit Patient’s Voice 2021 by CLARINESS.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.